Statin action enriches HDL3 in polyunsaturated phospholipids and plasmalogens and reduces LDL-derived phospholipid hydroperoxides in atherogenic mixed dyslipidemia

Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans

(2015) Carlos O. Mendivil et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Plasmalogens of high-density lipoproteins (HDL) are associated with coronary artery disease and anti-apoptotic activity of HDL

(2015) Iryna Sutter et al.   ATHEROSCLEROSIS

A Century of Cholesterol and Coronaries: From Plaques to Genes to Statins

(2015) Joseph L. Goldstein et al.   CELL

Statin action favors normalization of the plasma lipidome in the atherogenic mixed dyslipidemia of MetS: potential relevance to statin-associated dysglycemia

(2015) Peter J. Meikle et al.   JOURNAL OF LIPID RESEARCH

Dysfunctional HDL and atherosclerotic cardiovascular disease

(2015) Robert S. Rosenson et al.   Nature Reviews Cardiology

Regulation of High-Density Lipoprotein Metabolism

(2014) Kerry-Anne Rye et al.   CIRCULATION RESEARCH

Antioxidant Effects of Statins in the Management of Cardiometabolic Disorders

(2014) Soo Lim et al.   Journal of Atherosclerosis and Thrombosis

Dose-Dependent Effects of Rosuvastatin on the Plasma Sphingolipidome and Phospholipidome in the Metabolic Syndrome

(2014) Theodore W. K. Ng et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Triglycerides and cardiovascular disease

(2014) Børge G Nordestgaard et al.   LANCET

Small, Dense High-Density Lipoprotein-3 Particles Are Enriched in Negatively Charged Phospholipids

(2013) Laurent Camont et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effect of high-dose pitavastatin on glucose homeostasis in patients at elevated risk of new-onset diabetes: insights from the CAPITAIN and PREVAIL-US studies

(2013) M. J. Chapman et al.   CURRENT MEDICAL RESEARCH AND OPINION

Pitavastatin Increases HDL Particles Functionally Preserved with Cholesterol Efflux Capacity and Antioxidative Actions in Dyslipidemic Patients

(2013) Maki Miyamoto-Sasaki et al.   Journal of Atherosclerosis and Thrombosis

Unraveling the complexities of the HDL lipidome

(2013) Anatol Kontush et al.   JOURNAL OF LIPID RESEARCH

Plasma lipid profiling in a large population-based cohort

(2013) Jacquelyn M. Weir et al.   JOURNAL OF LIPID RESEARCH

The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management

(2013) Robert A Hegele et al.   Lancet Diabetes & Endocrinology

Plasmalogens the neglected regulatory and scavenging lipid species

(2011) Stefan Wallner et al.   CHEMISTRY AND PHYSICS OF LIPIDS

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

LDL-apheresis depletes apoE-HDL and pre-β1-HDL in familial hypercholesterolemia: relevance to atheroprotection

(2011) Alexina Orsoni et al.   JOURNAL OF LIPID RESEARCH

Effect of Two Intensive Statin Regimens on Progression of Coronary Disease

(2011) Stephen J. Nicholls et al.   NEW ENGLAND JOURNAL OF MEDICINE

Biological activities of HDL subpopulations and their relevance to cardiovascular disease

(2011) Laurent Camont et al.   TRENDS IN MOLECULAR MEDICINE

Pitavastatin decreases the expression of endothelial lipase both in vitro and in vivo

(2010) Y. Kojima et al.   CARDIOVASCULAR RESEARCH

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity

(2009) Amal Zerrad-Saadi et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Cholesteryl ester transfer protein: at the heart of the action of lipid-modulating therapy with statins, fibrates, niacin, and cholesteryl ester transfer protein inhibitors

(2009) M. J. Chapman et al.   EUROPEAN HEART JOURNAL

Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database

(2009) Philip J. Barter et al.   JOURNAL OF LIPID RESEARCH

The role of oxidized phospholipids in atherosclerosis: Fig. 1.

(2008) Judith A. Berliner et al.   JOURNAL OF LIPID RESEARCH

A novel function of lipoprotein [a] as a preferential carrier of oxidized phospholipids in human plasma

(2008) Claes Bergmark et al.   JOURNAL OF LIPID RESEARCH

Circulating Lipid Hydroperoxides Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease

(2008) Mary F. Walter et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Metabolic syndrome features small, apolipoprotein A-I-poor, triglyceride-rich HDL3 particles with defective anti-apoptotic activity

(2007) Juliana A. de Souza et al.   ATHEROSCLEROSIS